GNOM News and Press, Global X Genomics & Biotechnology ETF From 10/18/25

2025-10-18 02:30:00 ET By Zain Vawda Week in review Another week has passed by, and the US government shutdown continues. Despite this, the week was still full of volatility as markets grappled with the ongoing US-China stalemate as well as concerns around the US banking sec...

2025-10-10 06:30:00 ET While the threat of tariffs and drug pricing pressures have weighed on the outlook for healthcare stocks recently, some parts of the sector are beginning to stage a recovery. Ram Sampath, VP, Portfolio Research with TD Asset Management, joins MoneyTalk to discuss why ...

2025-10-07 12:05:00 ET By Diederik Stadig What does the Pfizer-Trump deal cover? The deal between the Trump Administration and Pfizer (PFE) provides clarity about the near-term future of the US patent-protected pharmaceutical sector after months of (tariff) uncertainty. ...

2025-09-30 12:30:00 ET The September 2025 edition of the S&P 500 equity sector rotation chartbook can be found here . You can read more about the methodology and underlying assets here . This chartbook has been prepared with 1y total return, which is a departure from the first v...

2025-09-26 11:49:00 ET Autonomous & Electric Vehicles Waymo Secures First New York City Permit as Its Rapid U.S. Expansion Continues ... Read the full article on Seeking Alpha For further details see: The Next Big Theme: September 2025

2025-09-24 02:40:00 ET By Vinay Thapar, CFA and Jane Bleeg AI is a potential boon to healthcare companies, but business fundamentals - not the latest science - are the true test of staying power. ... Read the full article on Seeking Alpha For further details see:...

2025-09-12 11:30:00 ET Pharma and biotech stocks have struggled lately as uncertainty over the potential impact of tariffs and pricing pressures. Jasper Hellweg, Security Analyst with Argus Research, joins MoneyTalk to discuss how new treatment types and U.S. policy changes could be cat...

2025-09-12 02:10:00 ET By Carrie King ... Read the full article on Seeking Alpha For further details see: Earnings Offer Evidence That U.S. Stocks Can Keep On Keepin' On

2025-09-12 01:10:00 ET By Shea Wihlborg Introduction Cardiovascular disease is the world’s leading killer and one of the most economically damaging, as its prevalence and costs have been rising. 1 While statins can reduce the risk of heart attacks by ~29%, 2 r...

2025-09-05 03:30:00 ET By Frank Coughlin In the second quarter, several overarching themes emerged from earnings calls, painting a picture of a business landscape in flux. Tariffs and policy uncertainty, which were dominant themes in Q1, continue to weigh on corporate strategy.....